Publications & Research

Study: PET predicts survival from sarcomas

Researchers from the Jonsson Comprehensive Cancer Center at UCLA studied 39 patients with soft-tissue sarcoma who received a PET scan to measure tumor metabolism prior to chemotherapy. The patients also were given a PET scan after the first round of chemotherapy.

Patients whose tumors demonstrated a 25% or more decrease in metabolic activity were determined later to have significant increased survival rates compared to those patients who had less than a 25% decrease, according to senior study author Dr. Fritz Eilber, associate professor of surgical oncology and director of the sarcoma program at the cancer center.

Click here to read the full article.

Click here to view the full study.

  • MITA Smart Initiative

    Promoting patient safety and enhancing the quality of medical imaging technology with MITA Smart Standards. Learn More

  • Fluoro Pharma

    Why I Joined MITA – FluoroPharma Medical, Inc.

    Hear from Thomas Tulip, Ph.D, President, FluoroPharma Medical, Inc. on why his organization joined MITA.

    Learn More